Acumen Pharmaceuticals, Inc. ABOS 深 沪
已收盘 05-15 16:00:00 美东时间
2.28
-0.110
-4.60%
华盛通- 最 高2.40
- 今 开2.35
- 成交量 39.02万股
- 最 低 2.26
- 昨 收 2.39
- 总市值 16.47万
- 52周最高 3.60
- 市盈率 静 --
- 换手率 0.54%
- 52周最低 0.9901
- 委 比 -50.77%
- 总股本 7.22万
- 历史最高 26.98
- 量 比 1.52
- 振 幅 5.86%
- 历史最低 0.8551
- 每 手 1
- 风险率 0.62%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Acumen Pharmaceuticals Reports Q1 2026 Results: Full Earnings Call Transcript
On Tuesday, Acumen Pharmaceuticals (NASDAQ:ABOS) discussed first-quarter financ...
05-12 20:50
Earnings Scheduled For May 12, 2026
Companies Reporting Before The Bell • Sionna Therapeutics (NASDAQ:SION) is proj...
05-12 19:11
Acumen Pharmaceuticals Q1 EPS $(0.33) Beats $(0.36) Estimate
Acumen Pharmaceuticals (NASDAQ:ABOS) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(0.36) by 8.33 percent. This is a 31.25 percent increase over losses of $(0.48) per share
05-12 19:01
Acumen Pharmaceuticals shares are trading lower after the company reported a year-over-year decrease in Q4 EPS results.
Acumen Pharmaceuticals shares are trading lower after the company reported a ye...
03-27 21:29
美股大行评级 | 大摩、高盛上调Denali Therapeutics目标价；Chewy、沛齐遭多家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Atossa Therapeutics"买入"评级，目标价从7美元升至25美元；Needham：维持Nkarta"买入"评级，目标价从10美元升至11美元
03-27 10:22
BTIG Reiterates Buy on Acumen Pharmaceuticals, Maintains $8 Price Target
BTIG analyst Thomas Shrader reiterates Acumen Pharmaceuticals (NASDAQ:ABOS) with a Buy and maintains $8 price target.
03-27 00:32
Acumen Pharmaceuticals Q4 EPS $(0.41) Beats $(0.43) Estimate
Acumen Pharmaceuticals (NASDAQ:ABOS) reported quarterly losses of $(0.41) per share which beat the analyst consensus estimate of $(0.43) by 5.09 percent. This is a 33.87 percent increase over losses of $(0.62) per share
03-26 20:23
Earnings Scheduled For March 26, 2026
Companies Reporting Before The Bell • ProShares UltraShort Russell2000 (NYSE:TW...
03-26 19:11
Acumen Pharmaceuticals shares are trading higher after the company announced a $35.75 million equity private placement at $3.30 per share.
Acumen Pharmaceuticals shares are trading higher after the company announced a ...
03-16 20:47
Market-Moving News for March 16th
NBIS: 17% | Nebius Announced 5-Year $12B AI Infrastructure Agreement With Meta To Provide Dedicated Capacity Across Multiple Locations Using NVIDIA Vera Rubin Platform Starting Early 2027 CTMX: 70%
03-16 19:30
